In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
Decoder
Blood vessels supply tumors with the nutrients they need to grow.
What Is Angiogenesis?

Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research.
In the Lab
Thomas Fuchs
Researchers Report Milestone in Use of Artificial Intelligence in Pathology

MSK researchers developed an artificial intelligence system to detect cancer on digitized microscope slides.
A Fred’s Team runner giving a high five
Your Impact: Celebrating Our Donors’ Support in 2021

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
In the Clinic
Hyperpolarized MRI
Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Support
Clasping hands
Understanding the Stigma of Lung Cancer

Researchers are studying the stigma associated with lung cancer to find ways to reduce people’s feelings of regret and hopelessness after diagnosis.
Inherited Mutations May Point to an Aggressive Form of Prostate Cancer

A team of Memorial Sloan Kettering researchers reports that prostate cancer often takes an aggressive course in patients who have inherited mutations in the genes <i>BRCA1</i> or <i>BRCA2</i>.
Q&A
Two doctors looking at a patient
Answers to Common Questions about Radiation Safety

MSK radiation therapy experts set the record straight about the safety of this effective treatment.
Mobile Health Unit
Education and Care on Wheels: MSK’s Mobile Health Unit Serves Communities across New York Metro Area

MSK’s Mobile Health Unit provides health education, screening, and navigation services to underserved communities in the New York metro area.
Laboratory coats hanging from pegs
MSK Research Highlights, November 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.
Charles Sawyers in his lab
A New Approach in Prostate Cancer: Targeting the Cells Surrounding the Tumor

Scientists have found a protein that empowers prostate tumors to resist hormone therapy.